• FDA's top vaccine regulator asserts COVID-19 vaccines caused at least 10 child deaths based on VAERS data reanalysis
  • Former FDA commissioners and experts challenge the claim, citing lack of published evidence and misuse of passive reporting systems
  • The controversy threatens to further erode pediatric vaccination rates and could lead to stricter regulatory requirements for all vaccines

A Regulatory Earthquake

An internal memo from Dr. Vinay Prasad, head of the FDA's Center for Biologics Evaluation and Research, has sent shockwaves through the pharmaceutical regulatory landscape. According to people familiar with the matter, Prasad's analysis of Vaccine Adverse Event Reporting System data from 2021-2024 identified 96 child deaths following COVID-19 vaccination, with "no fewer than 10" directly related to the shots. The memo, which has not been publicly released in full, proposes sweeping changes to vaccine regulation that could fundamentally alter how future vaccines are evaluated and approved.

What makes this development particularly explosive is the FDA's silence on supporting evidence. Multiple vaccine-safety experts who spoke on condition of anonymity noted that the agency has not published case details, methodological approaches, or peer-reviewed analyses explaining how causality was determined. "This represents a major departure from established pharmacovigilance practices," said one former FDA official who requested anonymity due to ongoing relationships with current agency staff. "VAERS is designed for signal detection, not proof of causation."

Mounting Pushback

The response from the scientific and regulatory communities has been swift and severe. Twelve former FDA commissioners issued a coordinated public statement criticizing the memo's reliance on unverified VAERS reports and warning that it proposes a "major shift" in vaccine regulation without adequate evidence. Their concerns echo those of infectious-disease specialists like Michael Osterholm and Amesh Adalja, who have called the claims "extraordinary" and demanded transparent, detailed evidence that has yet to materialize.

Efforts to restructure vaccine regulation have hit a snag as internal dissent grows. Multiple CBER staffers told colleagues they regarded the memo as "misleading" and "politically charged," according to people familiar with internal discussions. One staffer expressed concern that colleagues might seek transfers if the agency's approach to vaccine safety becomes politicized. The FDA did not respond to multiple requests for comment on the internal discord or the memo's specific claims.

Market and Policy Implications

Without a clear resolution, the controversy threatens to further depress already declining COVID-19 vaccine demand, particularly among pediatric populations. Analysts note that the memo's timing coincides with the CDC's Advisory Committee on Immunization Practices meeting on pediatric COVID vaccination policy, where observers expect the controversy to surface. The CDC has already shifted away from universal COVID-shot recommendations toward a more targeted, risk-based approach, but this new development could accelerate that trend.

Senator Bill Cassidy has requested a full Senate briefing, saying the FDA has not explained its verification process and that the public needs clarity. His office confirmed that they are preparing questions about how the agency determined causality from VAERS data alone. If Prasad's proposed regulatory changes were implemented, vaccine developers could face longer, more expensive trials and more stringent post-market requirements, potentially raising R&D costs across the entire vaccine sector.

Looking Ahead

The immediate focus remains on whether the FDA will publish detailed case reviews and methodology. Pressure is mounting for the agency to convene an independent body such as the National Academies to reassess the data, as recommended by several public health experts. Meanwhile, pediatricians report increased uncertainty among parents, despite what they describe as extensive evidence supporting the strong safety profile of COVID-19 vaccines for children.

Correction: An earlier version of this article stated that the FDA memo claimed 96 child deaths were caused by COVID-19 vaccines. The memo actually identified 96 deaths following vaccination and asserted that at least 10 were related to the shots.